Top Markets
#1 ADO Protocol ADO Protocol +193.12%
#2 Islamic Coin Islamic Coin +155.43%
#3 GoPlus Security GoPlus Security +48.69%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +17.54%
#6 Chia Chia +15.11%
#7 Casper Network Casper Network +13.73%
#8 Verus Coin Verus Coin +13.56%
#9 o1.exchange o1.exchange +12.82%
#10 Pons Pons +12.26%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Clasificación en acciones #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Precio por acción
$0.5099
Última sincronización: 2024-10-15
Capitalización bursátil
$7.60M
Cambio (1 día)
2.02%
Cambio (1 año)
0.00%
País
US
Comercio Anew Medical, Inc. (WENA)

Categoría

Healthcare
Ratio P/B de Anew Medical, Inc. (WENA)
Ratio P/B al August 2026 TTM: 0.63
Según los informes financieros más recientes y el precio de las acciones de Anew Medical, Inc., el ratio P/B actual (TTM) es 0.63. Al final de 2022, el ratio P/B era 0.79.
Historial del ratio P/B de Anew Medical, Inc. desde 2021 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 0.63 -87.86%
2023 5.20 561.31%
2022 0.79 -98.96%
2021 75.61 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 904.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 888.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 448.09%
BE